Importance of immune monitoring approaches and the use of immune checkpoints for the treatment of diffuse intrinsic pontine glioma: From bench to clinic and vice versa (Review)
/in Brain Tumors in Children, International Publications /von 2018-02-23 / Int. J. Oncol. 2018 Apr;52(4):1041-1056Non-Invasive Radiofrequency Field Treatment of 4T1 Breast Tumors Induces T-cell Dependent Inflammatory Response
/in Breast Cancer, Hyperthermia, International Publications /von 2018-02-22 / Sci Rep 2018 Feb;8(1):3474Anti-cancer vaccine therapy for hematologic malignancies: An evolving era
/in Acute Leukemia, Checkpoint-Inhibitors, Chronic Leukemia, Dendritic Cells, International Publications /von 2018-02-15 / Blood Rev. 2018 Jul;32(4):312-325Potentiating prostate cancer immunotherapy with oncolytic viruses
/in International Publications, Newcastle Disease Virus, Prostate Cancer /von 2018-02-13 / Nat Rev Urol 2018 Apr;15(4):235-250Myeloid and plasmacytoid dendritic cell vaccinations for castration-resistant prostate cancer patients.
/in Dendritic Cells, International Publications, Prostate Cancer /von 2018-02-08 / J Clin Oncol 36, 2018 (suppl 6S; abstr 219)Poly(I:C) enhanced anti-cervical cancer immunities induced by dendritic cells-derived exosomes
/in Cervical Cancer, Dendritic Cells, Exosome, International Publications /von 2018-02-08 / Int. J. Biol. Macromol. 2018 Jul;113:1182-1187Efficacy of intracellular immune checkpoint-silenced DC vaccine
/in Acute Leukemia, Dendritic Cells, International Publications /von 2018-02-08 / JCI Insight 2018 Feb;3(3)Immuntherapie beim Prostatakarzinom: Kanadische Arbeitsgruppe stellt den aktuellen Stand vor
/0 Kommentare/in Externe Meldungen, IOZK In der Presse /von IOZKRe-Emergence of Dendritic Cell Vaccines for Cancer Treatment
/in Dendritic Cells, International Publications /von 2018-02-01 / Trends Cancer 2018 02;4(2):119-137
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution